Bayer is nearing the end of the road for glyphosate, executives say

Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.

Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.

More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.

Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.

Related Stories
Secretary Rollins’ plan targets high costs, labor challenges, and export growth, delivering relief at home while building markets abroad.
Bird owners are urged to practice strong biosecurity as fall brings a rise in high path avian flu cases.
The ag machinery leader is betting that, by throwing the weight of their established brand behind this cutting-edge technology, more producers will be motivated to adopt it sooner rather than later.
The Big Beautiful Bill has the potential to keep rural residents living and operating in their home communities.
Michigan corn farmer and NCGA Vice President-Elect Matt Frostic will lead the task force. He joined us on Thursday to share his insights on the escalating corn crisis.
Speaking about his administration’s tariff strategy, Trump acknowledged that producers could face financial strain in the short term but promised stopgap support.